H. R. 2483 
One Hundred Nineteenth Congress 
of the 
United States of America 
AT THE FIRST SESSION 
Begun and held at the City of Washington on Friday, 
the third day of January, two thousand and twenty-five 
An Act 
To reauthorize certain programs that provide for opioid use disorder prevention, 
treatment, and recovery, and for other purposes. 
Be it enacted by the Senate and House of Representatives of 
the United States of America in Congress assembled, 
SECTION 1. SHORT TITLE; TABLE OF CONTENTS. 
(a) SHORT TITLE.—This Act may be cited as the ‘‘SUPPORT 
for Patients and Communities Reauthorization Act of 2025’’. 
(b) TABLE OF CONTENTS.—The table of contents for this Act 
is as follows: 
Sec. 1. Short title; table of contents. 
TITLE I—PREVENTION 
Sec. 101. Prenatal and postnatal health. 
Sec. 102. Monitoring and education regarding infections associated with illicit drug 
use and other risk factors. 
Sec. 103. Preventing overdoses of controlled substances. 
Sec. 104. Support for individuals and families impacted by fetal alcohol spectrum 
disorder. 
Sec. 105. Promoting state choice in PDMP systems. 
Sec. 106. First responder training program. 
Sec. 107. Donald J. Cohen National Child Traumatic Stress Initiative. 
Sec. 108. Protecting suicide prevention lifeline from cybersecurity incidents. 
Sec. 109. Monitoring and reporting of child, youth, and adult trauma. 
Sec. 110. Bruce’s law. 
Sec. 111. Guidance on at-home drug disposal systems. 
Sec. 112. Assessment of opioid drugs and actions. 
Sec. 113. Grant program for State and Tribal response to opioid use disorders. 
TITLE II—TREATMENT 
Sec. 201. Residential treatment program for pregnant and postpartum women. 
Sec. 202. Improving access to addiction medicine providers. 
Sec. 203. Mental and behavioral health education and training grants. 
Sec. 204. Loan repayment program for substance use disorder treatment workforce. 
Sec. 205. Development and dissemination of model training programs for substance 
use disorder patient records. 
Sec. 206. Task force on best practices for trauma-informed identification, referral, 
and support. 
Sec. 207. Grants to enhance access to substance use disorder treatment. 
Sec. 208. State guidance related to individuals with serious mental illness and chil-
dren with serious emotional disturbance. 
Sec. 209. Reviewing the scheduling of approved products containing a combination 
of buprenorphine and naloxone. 
Sec. 210. References to opioid overdose reversal agents in HHS grant programs. 
Sec. 211. Roundtable on using health information technology to improve mental 
health and substance use care outcomes. 
TITLE III—RECOVERY 
Sec. 301. Building communities of recovery. 
Sec. 302. Peer support technical assistance center. 
Sec. 303. Comprehensive opioid recovery centers.
H. R. 2483—2 
Sec. 304. Youth prevention and recovery. 
Sec. 305. CAREER Act. 
Sec. 306. Addressing economic and workforce impacts of the opioid crisis. 
Sec. 307. Review of information related to funding opportunities under programs 
administered by SAMHSA. 
TITLE IV—MISCELLANEOUS MATTERS 
Sec. 401. Delivery of a controlled substance by a pharmacy to a prescribing practi-
tioner. 
Sec. 402. Required training for prescribers of controlled substances. 
TITLE I—PREVENTION 
SEC. 101. PRENATAL AND POSTNATAL HEALTH. 
Section 317L(d) of the Public Health Service Act (42 U.S.C. 
247b–13(d)) is amended by striking ‘‘such sums as may be necessary 
for each of the fiscal years 2019 through 2023’’ and inserting 
‘‘$4,250,000 for each of fiscal years 2026 through 2030’’. 
SEC. 102. MONITORING AND EDUCATION REGARDING INFECTIONS 
ASSOCIATED WITH ILLICIT DRUG USE AND OTHER RISK 
FACTORS. 
Section 317N(d) of the Public Health Service Act (42 U.S.C. 
247b–15(d)) is amended by striking ‘‘fiscal years 2019 through 2023’’ 
and inserting ‘‘fiscal years 2026 through 2030’’. 
SEC. 103. PREVENTING OVERDOSES OF CONTROLLED SUBSTANCES. 
(a) IN GENERAL.—Section 392A of the Public Health Service 
Act (42 U.S.C. 280b–1) is amended— 
(1) in subsection (a)(2)— 
(A) in subparagraph (C), by inserting ‘‘and associated 
risks’’ before the period at the end; and 
(B) in subparagraph (D), by striking ‘‘opioids’’ and 
inserting ‘‘substances causing overdose’’; and 
(2) in subsection (b)(2)— 
(A) in subparagraph (B), by inserting ‘‘, and associated 
risk factors,’’ after ‘‘such overdoses’’; 
(B) in subparagraph (C), by striking ‘‘coding’’ and 
inserting ‘‘monitoring and identifying’’; 
(C) in subparagraph (E)— 
(i) by inserting a comma after ‘‘public health lab-
oratories’’; and 
(ii) by inserting ‘‘and other emerging substances 
related’’ after ‘‘analogues’’; and 
(D) in subparagraph (F), by inserting ‘‘and associated 
risk factors’’ after ‘‘overdoses’’. 
(b) ADDITIONAL GRANTS.—Section 392A(a)(3) of the Public 
Health Service Act (42 U.S.C. 280b–1(a)(3)) is amended— 
(1) in the matter preceding subparagraph (A), by striking 
‘‘and Indian Tribes—’’ and inserting ‘‘and Indian Tribes for 
the following purposes:’’; 
(2) by amending subparagraph (A) to read as follows: 
‘‘(A) To carry out innovative projects for grantees to 
detect, identify, and rapidly respond to controlled substance 
misuse, abuse, and overdoses, and associated risk factors, 
including changes in patterns of such controlled substance 
use. Such projects may include the use of innovative, evi-
dence-based strategies for detecting such patterns, such 
as wastewater surveillance, if proven to support actionable
H. R. 2483—3 
prevention strategies, in a manner consistent with 
applicable Federal and State privacy laws.’’; and 
(3) in subparagraph (B), by striking ‘‘for any’’ and inserting 
‘‘For any’’. 
(c) AUTHORIZATION OF APPROPRIATIONS.—Section 392A(e) of the 
Public Health Service Act (42 U.S.C. 280b–1(e)) is amended by 
striking ‘‘$496,000,000 for each of fiscal years 2019 through 2023’’ 
and inserting ‘‘$505,579,000 for each of fiscal years 2026 through 
2030’’. 
SEC. 104. SUPPORT FOR INDIVIDUALS AND FAMILIES IMPACTED BY 
FETAL ALCOHOL SPECTRUM DISORDER. 
(a) IN GENERAL.—Part O of title III of the Public Health Service 
Act (42 U.S.C. 280f et seq.) is amended to read as follows: 
‘‘PART O—FETAL ALCOHOL SPECTRUM DIS-
ORDER PREVENTION AND SERVICES PRO-
GRAM 
‘‘SEC. 399H. FETAL ALCOHOL SPECTRUM DISORDERS PREVENTION, 
INTERVENTION, AND SERVICES DELIVERY PROGRAM. 
‘‘(a) IN GENERAL.—The Secretary shall establish or continue 
activities to support a comprehensive fetal alcohol spectrum dis-
orders (referred to in this section as ‘FASD’) education, prevention, 
identification, intervention, and services delivery program, which 
may include— 
‘‘(1) an education and public awareness program to support, 
conduct, and evaluate the effectiveness of— 
‘‘(A) educational programs targeting health professions 
schools, social and other supportive services, educators and 
counselors and other service providers in all phases of 
childhood development, and other relevant service pro-
viders, concerning the prevention, identification, and provi-
sion of services for infants, children, adolescents, and adults 
with FASD; 
‘‘(B) strategies to educate school-age children, including 
pregnant and high-risk youth, concerning FASD; 
‘‘(C) public and community awareness programs con-
cerning FASD; and 
‘‘(D) strategies to coordinate information and services 
across affected community agencies, including agencies pro-
viding social services such as foster care, adoption, and 
social work, agencies providing health services, and agen-
cies involved in education, vocational training, and civil 
and criminal justice; 
‘‘(2) supporting and conducting research on FASD, as appro-
priate, including to— 
‘‘(A) develop appropriate medical diagnostic methods 
for identifying FASD; and 
‘‘(B) develop effective culturally and linguistically 
appropriate evidence-based or evidence-informed interven-
tions and appropriate supports for preventing prenatal 
alcohol exposure, which may co-occur with exposure to 
other substances;
H. R. 2483—4 
‘‘(3) building State and Tribal capacity for the identification, 
treatment, and support of individuals with FASD and their 
families, which may include— 
‘‘(A) utilizing and adapting existing Federal, State, or 
Tribal programs to include FASD identification and FASD- 
informed support; 
‘‘(B) developing and expanding screening and diag-
nostic capacity for FASD; 
‘‘(C) developing, implementing, and evaluating targeted 
FASD-informed intervention programs for FASD; 
‘‘(D) providing training with respect to FASD for profes-
sionals across relevant sectors; and 
‘‘(E) disseminating information about FASD and sup-
port services to affected individuals and their families; 
and 
‘‘(4) an applied research program concerning intervention 
and prevention to support and conduct service demonstration 
projects, clinical studies and other research models providing 
advocacy, educational and vocational training, counseling, med-
ical and mental health, and other supportive services, as well 
as models that integrate and coordinate such services, that 
are aimed at the unique challenges facing individuals with 
fetal alcohol spectrum disorder or fetal alcohol effect and their 
families. 
‘‘(b) GRANTS AND TECHNICAL ASSISTANCE.— 
‘‘(1) IN
GENERAL.—The Secretary may award grants, 
cooperative agreements and contracts and provide technical 
assistance to eligible entities to carry out subsection (a). 
‘‘(2) ELIGIBLE ENTITIES.—To be eligible to receive a grant, 
or enter into a cooperative agreement or contract, under this 
section, an entity shall— 
‘‘(A) be a State, Indian Tribe or Tribal organization, 
local government, scientific or academic institution, or non-
profit organization; and 
‘‘(B) prepare and submit to the Secretary an application 
at such time, in such manner, and containing such informa-
tion as the Secretary may require, including a description 
of the activities that the entity intends to carry out using 
amounts received under this section. 
‘‘(3) ADDITIONAL
APPLICATION
CONTENTS.—The Secretary 
may require that an eligible entity include in the application 
submitted under paragraph (2)(B)— 
‘‘(A) a designation of an individual to serve as a FASD 
State or Tribal coordinator of activities such eligible entity 
proposes to carry out through a grant, cooperative agree-
ment, or contract under this section; and 
‘‘(B) a description of an advisory committee the entity 
will establish to provide guidance for the entity on devel-
oping and implementing a statewide or Tribal strategic 
plan to prevent FASD and provide for the identification, 
treatment, and support of individuals with FASD and their 
families. 
‘‘(c) DEFINITION OF FASD-INFORMED.—For purposes of this sec-
tion, the term ‘FASD-informed’, with respect to support or an inter-
vention program, means that such support or intervention program 
uses culturally and linguistically informed evidence-based or prac-
tice-based interventions and appropriate resources to support an
H. R. 2483—5 
improved quality of life for an individual with FASD and the family 
of such individual. 
‘‘SEC. 399I. STRENGTHENING CAPACITY AND EDUCATION FOR FETAL 
ALCOHOL SPECTRUM DISORDERS. 
‘‘(a) IN GENERAL.—The Secretary shall award grants, contracts, 
or cooperative agreements, as the Secretary determines appropriate, 
to public or nonprofit private entities with demonstrated expertise 
in the field of fetal alcohol spectrum disorders (referred to in this 
section as ‘FASD’). Such awards shall be for the purposes of building 
local, Tribal, State, and nationwide capacities to prevent the occur-
rence of FASD by carrying out the programs described in subsection 
(b). 
‘‘(b) PROGRAMS.—An entity receiving an award under subsection 
(a) may use such award for the following purposes: 
‘‘(1) Developing and supporting public education and out-
reach activities to raise public awareness of the risks associated 
with alcohol consumption during pregnancy. 
‘‘(2) Acting as a clearinghouse for evidence-based resources 
on FASD prevention, identification, and culturally and linguis-
tically appropriate best practices to help inform systems of 
care for individuals with FASD across their lifespan. 
‘‘(3) Increasing awareness and understanding of efficacious, 
evidence-based screening tools and culturally and linguistically 
appropriate evidence-based intervention services and best prac-
tices, which may include improving the capacity for State, 
Tribal, and local affiliates. 
‘‘(4) Providing technical assistance to recipients of grants, 
cooperative agreements, or contracts under section 399H, as 
appropriate. 
‘‘(c) APPLICATION.—To be eligible for a grant, contract, or 
cooperative agreement under this section, an entity shall submit 
to the Secretary an application at such time, in such manner, 
and containing such information as the Secretary may require. 
‘‘(d) SUBCONTRACTING.—A public or private nonprofit entity 
may carry out the following activities required under this section 
through contracts or cooperative agreements with other public and 
private nonprofit entities with demonstrated expertise in FASD: 
‘‘(1) Resource development and dissemination. 
‘‘(2) Intervention services. 
‘‘(3) Training and technical assistance. 
‘‘SEC. 399J. AUTHORIZATION OF APPROPRIATIONS. 
‘‘There are authorized to be appropriated to carry out this 
part $12,500,000 for each of fiscal years 2026 through 2030.’’. 
(b) REPORT.—Not later than 4 years after the date of enactment 
of this Act, and every year thereafter, the Secretary of Health 
and Human Services shall prepare and submit to the Committee 
on Health, Education, Labor, and Pensions of the Senate and the 
Committee on Energy and Commerce of the House of Representa-
tives a report containing— 
(1) a review of the activities carried out pursuant to sections 
399H and 399I of the Public Health Service Act, as amended, 
to advance public education and awareness of fetal alcohol 
spectrum disorders (referred to in this section as ‘‘FASD’’); 
(2) a description of— 
(A) the activities carried out pursuant to such sections 
399H and 399I to identify, prevent, and treat FASD; and
H. R. 2483—6 
(B) methods used to evaluate the outcomes of such 
activities; and 
(3) an assessment of activities carried out pursuant to 
such sections 399H and 399I to support individuals with FASD. 
SEC. 105. PROMOTING STATE CHOICE IN PDMP SYSTEMS. 
Section 399O(h) of the Public Health Service Act (42 U.S.C. 
280g–3(h)) is amended by adding at the end the following: 
‘‘(5) PROMOTING STATE CHOICE.—Nothing in this section 
shall be construed to authorize the Secretary to require States 
to use a specific vendor or a specific interoperability connection 
other than to align with nationally recognized, consensus-based 
open standards, such as in accordance with sections 3001 and 
3004.’’. 
SEC. 106. FIRST RESPONDER TRAINING PROGRAM. 
Section 546 of the Public Health Service Act (42 U.S.C. 290ee– 
1) is amended— 
(1) in subsection (a), by striking ‘‘tribes and tribal’’ and 
inserting ‘‘Tribes and Tribal’’; 
(2) in subsections (a), (c), and (d)— 
(A) by striking ‘‘approved or cleared’’ each place it 
appears and inserting ‘‘approved, cleared, or otherwise 
legally marketed’’; and 
(B) by striking ‘‘opioid’’ each place it appears; 
(3) in subsection (f)— 
(A) by striking ‘‘approved or cleared’’ each place it 
appears and inserting ‘‘approved, cleared, or otherwise 
legally marketed’’; 
(B) in paragraph (1), by striking ‘‘opioid’’; 
(C) in paragraph (2)— 
(i) by striking ‘‘opioid and heroin’’ and inserting 
‘‘opioid, heroin, and other drug’’; and 
(ii) by striking ‘‘opioid overdose’’ and inserting 
‘‘overdose’’; and 
(D) in paragraph (3), by striking ‘‘opioid and heroin’’; 
and 
(4) in subsection (h), by striking ‘‘$36,000,000 for each 
of fiscal years 2019 through 2023’’ and inserting ‘‘$57,000,000 
for each of fiscal years 2026 through 2030’’. 
SEC. 107. DONALD J. COHEN NATIONAL CHILD TRAUMATIC STRESS 
INITIATIVE. 
(a) TECHNICAL AMENDMENT.—The second part G of title V 
of the Public Health Service Act (42 U.S.C. 290kk et seq.), as 
added by section 144 of the Community Renewal Tax Relief Act 
of 2000 (Public Law 106–554), is amended— 
(1) by redesignating such part as part J; and 
(2) by redesignating sections 581 through 584 as sections 
596 through 596C, respectively. 
(b) IN GENERAL.—Section 582 of the Public Health Service 
Act (42 U.S.C. 290hh–1) is amended— 
(1) in the section heading, by striking ‘‘VIOLENCE RELATED 
STRESS’’ and inserting ‘‘TRAUMATIC EVENTS’’; 
(2) in subsection (a)— 
(A) in the matter preceding paragraph (1), by striking 
‘‘tribes and tribal’’ and inserting ‘‘Tribes and Tribal’’; and
H. R. 2483—7 
(B) in paragraph (2), by inserting ‘‘and dissemination’’ 
after ‘‘the development’’; 
(3) in subsection (b), by inserting ‘‘and dissemination’’ after 
‘‘the development’’; 
(4) in subsection (d)— 
(A) by striking ‘‘The NCTSI’’ and inserting the fol-
lowing: 
‘‘(1) COORDINATING CENTER.—The NCTSI’’; and 
(B) by adding at the end the following: 
‘‘(2) NCTSI GRANTEES.—In carrying out subsection (a)(2), 
NCTSI grantees shall develop trainings and other resources, 
as applicable and appropriate, to support implementation of 
the evidence-based practices developed and disseminated under 
such subsection.’’; 
(5) in subsection (e)— 
(A) by redesignating paragraphs (1) and (2) as subpara-
graphs (A) and (B), respectively, and adjusting the margins 
accordingly; 
(B) in subparagraph (A), as so redesignated, by 
inserting ‘‘and implementation’’ after ‘‘the dissemination’’; 
(C) by striking ‘‘The NCTSI’’ and inserting the fol-
lowing: 
‘‘(1) COORDINATING CENTER.—The NCTSI’’; and 
(D) by adding at the end the following: 
‘‘(2) NCTSI GRANTEES.—NCTSI grantees shall, as appro-
priate, collaborate with other such grantees, the NCTSI coordi-
nating center, and the Secretary in carrying out subsections 
(a)(2) and (d)(2).’’; 
(6) by amending subsection (h) to read as follows: 
‘‘(h) APPLICATION AND EVALUATION.—To be eligible to receive 
a grant, contract, or cooperative agreement under subsection (a), 
a public or nonprofit private entity or an Indian Tribe or Tribal 
organization shall submit to the Secretary an application at such 
time, in such manner, and containing such information and assur-
ances as the Secretary may require, including— 
‘‘(1) a plan for the evaluation of the activities funded under 
the grant, contract, or agreement, including both process and 
outcomes evaluation, and the submission of an evaluation at 
the end of the project period; and 
‘‘(2) a description of how such entity, Indian Tribe, or 
Tribal organization will support efforts led by the Secretary 
or the NCTSI coordinating center, as applicable, to evaluate 
activities carried out under this section.’’; and 
(7) by amending subsection (j) to read as follows: 
‘‘(j) AUTHORIZATION OF APPROPRIATIONS.—There is authorized 
to be appropriated to carry out this section— 
‘‘(1) $98,887,000 for fiscal year 2026; 
‘‘(2) $98,887,000 for fiscal year 2027; 
‘‘(3) $98,887,000 for fiscal year 2028; 
‘‘(4) $100,000,000 for fiscal year 2029; and 
‘‘(5) $100,000,000 for fiscal year 2030.’’. 
SEC. 108. PROTECTING SUICIDE PREVENTION LIFELINE FROM CYBER-
SECURITY INCIDENTS. 
(a) NATIONAL SUICIDE PREVENTION LIFELINE PROGRAM.—Sec-
tion 520E–3(b) of the Public Health Service Act (42 U.S.C. 290bb– 
36c(b)) is amended—
H. R. 2483—8 
(1) in paragraph (4), by striking ‘‘and’’ at the end; 
(2) in paragraph (5), by striking the period at the end 
and inserting ‘‘; and’’; and 
(3) by adding at the end the following: 
‘‘(6) taking such steps as may be necessary to ensure the 
suicide prevention hotline is protected from cybersecurity 
incidents and eliminates known cybersecurity vulnerabilities.’’. 
(b) REPORTING.—Section 520E–3 of the Public Health Service 
Act (42 U.S.C. 290bb–36c) is amended— 
(1) by redesignating subsection (f) as subsection (g); and 
(2) by inserting after subsection (e) the following: 
‘‘(f) CYBERSECURITY REPORTING.— 
‘‘(1) NOTIFICATION.— 
‘‘(A) IN
GENERAL.—The program’s network adminis-
trator receiving Federal funding pursuant to subsection 
(a) shall report to the Assistant Secretary, in a manner 
that protects personal privacy, consistent with applicable 
Federal and State privacy laws— 
‘‘(i) any identified cybersecurity vulnerabilities to 
the program within a reasonable amount of time after 
identification of such a vulnerability; and 
‘‘(ii) any identified cybersecurity incidents to the 
program within a reasonable amount of time after 
identification of such incident. 
‘‘(B) LOCAL AND REGIONAL CRISIS CENTERS.—Local and 
regional crisis centers participating in the program shall 
report to the program’s network administrator identified 
under subparagraph (A), in a manner that protects personal 
privacy, consistent with applicable Federal and State pri-
vacy laws— 
‘‘(i) any identified cybersecurity vulnerabilities to 
the program within a reasonable amount of time after 
identification of such vulnerability; and 
‘‘(ii) any identified cybersecurity incidents to the 
program within a reasonable amount of time after 
identification of such incident. 
‘‘(2) NOTIFICATION.—If the program’s network adminis-
trator receiving funding pursuant to subsection (a) discovers, 
or is informed by a local or regional crisis center pursuant 
to paragraph (1)(B) of, a cybersecurity vulnerability or incident, 
within a reasonable amount of time after such discovery or 
receipt of information, such entity shall report the vulnerability 
or incident to the Assistant Secretary. 
‘‘(3) CLARIFICATION.— 
‘‘(A) OVERSIGHT.— 
‘‘(i) LOCAL AND REGIONAL CRISIS CENTERS.—Except 
as provided in clause (ii), local and regional crisis cen-
ters participating in the program shall oversee all tech-
nology each center employs in the provision of services 
as a participant in the program. 
‘‘(ii) NETWORK
ADMINISTRATOR.—The program’s 
network administrator receiving Federal funding 
pursuant to subsection (a) shall oversee the technology 
each crisis center employs in the provision of services 
as a participant in the program if such oversight 
responsibilities are established in the applicable net-
work participation agreement.
H. R. 2483—9 
‘‘(B) SUPPLEMENT, NOT SUPPLANT.—The cybersecurity 
incident reporting requirements under this subsection shall 
supplement, and not supplant, cybersecurity incident 
reporting requirements under other provisions of applicable 
Federal law that are in effect on the date of the enactment 
of the SUPPORT for Patients and Communities Reauthor-
ization Act of 2025.’’. 
(c) STUDY.—Not later than 180 days after the date of the 
enactment of this Act, the Comptroller General of the United States 
shall— 
(1) conduct and complete a study that evaluates cybersecu-
rity risks and vulnerabilities associated with the 9–8–8 
National Suicide Prevention Lifeline; and 
(2) submit a report on the findings of such study to the 
Committee on Health, Education, Labor, and Pensions of the 
Senate and the Committee on Energy and Commerce of the 
House of Representatives. 
SEC. 109. MONITORING AND REPORTING OF CHILD, YOUTH, AND 
ADULT TRAUMA. 
Section 7131(e) of the SUPPORT for Patients and Communities 
Act (42 U.S.C. 242t(e)) is amended by striking ‘‘$2,000,000 for 
each of fiscal years 2019 through 2023’’ and inserting ‘‘$9,000,000 
for each of fiscal years 2026 through 2030’’. 
SEC. 110. BRUCE’S LAW. 
(a) YOUTH PREVENTION AND RECOVERY.—Section 7102(c) of the 
SUPPORT for Patients and Communities Act (42 U.S.C. 290bb– 
7a(c)) is amended— 
(1) in paragraph (3)(A)(i), by inserting ‘‘, which may include 
strategies to increase education and awareness of the potency 
and dangers of synthetic opioids (including drugs contaminated 
with fentanyl) and, as appropriate, other emerging drug use 
or misuse issues’’ before the semicolon; and 
(2) in paragraph (4)(A), by inserting ‘‘and strategies to 
increase education and awareness of the potency and dangers 
of synthetic opioids (including drugs contaminated with 
fentanyl) and, as appropriate, emerging drug use or misuse 
issues’’ before the semicolon. 
(b) INTERDEPARTMENTAL SUBSTANCE USE DISORDERS COORDI-
NATING COMMITTEE.—Section 7022 of the SUPPORT for Patients 
and Communities Act (42 U.S.C. 290aa note) is amended— 
(1) by striking subsection (g) and inserting the following: 
‘‘(g) WORKING GROUPS.— 
‘‘(1) IN GENERAL.—The Committee may establish working 
groups for purposes of carrying out the duties described in 
subsection (e). Any such working group shall be composed of 
members of the Committee (or the designees of such members) 
and may hold such meetings as are necessary to carry out 
the duties delegated to the working group. 
‘‘(2) ADDITIONAL FEDERAL INTERAGENCY WORK GROUP ON 
FENTANYL CONTAMINATION OF ILLEGAL DRUGS.— 
‘‘(A) ESTABLISHMENT.—The Secretary, acting through 
the Committee, shall establish a Federal Interagency Work 
Group on Fentanyl Contamination of Illegal Drugs (referred 
to in this paragraph as the ‘Work Group’) consisting of 
representatives from relevant Federal departments and 
agencies on the Committee.
H. R. 2483—10 
‘‘(B) CONSULTATION.—The Work Group shall consult 
with relevant stakeholders and subject matter experts, 
including— 
‘‘(i) State, Tribal, and local subject matter experts 
in reducing, preventing, and responding to drug over-
dose caused by fentanyl contamination of illicit drugs; 
and 
‘‘(ii) family members of both adults and youth who 
have overdosed by fentanyl contaminated illicit drugs. 
‘‘(C) DUTIES.—The Work Group shall— 
‘‘(i) examine Federal efforts to reduce and prevent 
drug overdose by fentanyl-contaminated illicit drugs; 
‘‘(ii) identify strategies to improve State, Tribal, 
and local responses to overdose by fentanyl-contami-
nated illicit drugs; 
‘‘(iii) coordinate with the Secretary, as appropriate, 
in carrying out activities to raise public awareness 
of synthetic opioids and other emerging drug use and 
misuse issues; 
‘‘(iv) make recommendations to Congress for 
improving Federal programs, including with respect 
to the coordination of efforts across such programs; 
and 
‘‘(v) make recommendations for educating youth 
on the potency and dangers of drugs contaminated 
by fentanyl. 
‘‘(D) ANNUAL REPORT TO SECRETARY.—The Work Group 
shall annually prepare and submit to the Secretary, the 
Committee on Health, Education, Labor, and Pensions of 
the Senate, and the Committee on Energy and Commerce 
and the Committee on Education and Workforce of the 
House of Representatives, a report on the activities carried 
out by the Work Group under subparagraph (C), including 
recommendations to reduce and prevent drug overdose by 
fentanyl contamination of illegal drugs, in all populations, 
and specifically among youth at risk for substance misuse.’’; 
and 
(2) by striking subsection (i) and inserting the following: 
‘‘(i) SUNSET.—The Committee shall terminate on September 
30, 2030.’’. 
SEC. 111. GUIDANCE ON AT-HOME DRUG DISPOSAL SYSTEMS. 
(a) IN GENERAL.—Not later than one year after the date of 
enactment of this Act, the Secretary of Health and Human Services, 
in consultation with the Administrator of the Drug Enforcement 
Administration, shall publish guidance to facilitate the use of at- 
home safe disposal systems for applicable drugs. 
(b) CONTENTS.—The guidance under subsection (a) shall 
include— 
(1) recommended standards for effective at-home drug dis-
posal systems to meet applicable requirements enforced by 
the Food and Drug Administration; 
(2) recommended information to include as instructions 
for use to disseminate with at-home drug disposal systems; 
(3) best practices and educational tools to support the use 
of an at-home drug disposal system, as appropriate; and
H. R. 2483—11 
(4) recommended use of licensed health providers for the 
dissemination of education, instruction, and at-home drug dis-
posal systems, as appropriate. 
SEC. 112. ASSESSMENT OF OPIOID DRUGS AND ACTIONS. 
(a) IN GENERAL.—Not later than one year after the date of 
enactment of this Act, the Secretary of Health and Human Services 
(referred to in this section as the ‘‘Secretary’’) shall publish on 
the website of the Food and Drug Administration (referred to in 
this section as the ‘‘FDA’’) a report that outlines a plan for assessing 
opioid analgesic drugs that are approved under section 505 of 
the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 355) that 
addresses the public health effects of such opioid analgesic drugs 
as part of the benefit-risk assessment and the activities of the 
FDA that relate to facilitating the development of nonaddictive 
medical products intended to treat pain or addiction. Such report 
shall include— 
(1) an update on the actions taken by the FDA to consider 
the effectiveness, safety, benefit-risk profile, and use of 
approved opioid analgesic drugs; 
(2) a timeline for an assessment of the potential need, 
as appropriate, for labeling changes, revised or additional post-
marketing requirements, enforcement actions, or withdrawals 
for opioid analgesic drugs; 
(3) an overview of the steps that the FDA has taken to 
support the development and approval of nonaddictive medical 
products intended to treat pain or addiction, and actions 
planned to further support the development and approval of 
such products; and 
(4) an overview of the consideration by the FDA of clinical 
trial methodologies for analgesic drugs, including the enriched 
enrollment randomized withdrawal methodology, and the bene-
fits and drawbacks associated with different trial methodologies 
for such drugs, incorporating any public input received under 
subsection (b). 
(b) PUBLIC INPUT.—In carrying out subsection (a), the Secretary 
shall provide an opportunity for public input concerning the regula-
tion by the FDA of opioid analgesic drugs, including scientific evi-
dence that relates to conditions of use, safety, or benefit-risk assess-
ment (including consideration of the public health effects) of such 
opioid analgesic drugs. 
SEC. 113. GRANT PROGRAM FOR STATE AND TRIBAL RESPONSE TO 
OPIOID USE DISORDERS. 
The activities carried out pursuant to section 1003(b)(4)(A) 
of the 21st Century Cures Act (42 U.S.C. 290ee–3a(b)(4)(A)) may 
include facilitating access to products used to prevent overdose 
deaths by detecting the presence of one or more substances, such 
as fentanyl and xylazine test strips, to the extent the purchase 
and possession of such products is consistent with Federal and 
State law.
H. R. 2483—12 
TITLE II—TREATMENT 
SEC. 201. RESIDENTIAL TREATMENT PROGRAM FOR PREGNANT AND 
POSTPARTUM WOMEN. 
Section 508 of the Public Health Service Act (42 U.S.C. 290bb– 
1) is amended— 
(1) in subsection (d)(11)(C), by striking ‘‘providing health 
services’’ and inserting ‘‘providing health care services’’; 
(2) in subsection (g)— 
(A) by inserting ‘‘a plan describing’’ after ‘‘will provide’’; 
and 
(B) by adding at the end the following: ‘‘Such plan 
may include a description of how such applicant will target 
outreach 
to 
women 
disproportionately 
impacted 
by 
maternal substance use disorder.’’; and 
(3) in subsection (s), by striking ‘‘$29,931,000 for each of 
fiscal years 2019 through 2023’’ and inserting ‘‘$38,931,000 
for each of fiscal years 2026 through 2030’’. 
SEC. 202. IMPROVING ACCESS TO ADDICTION MEDICINE PROVIDERS. 
Section 597 of the Public Health Service Act (42 U.S.C. 290ll) 
is amended— 
(1) in subsection (a)(1), by inserting ‘‘diagnosis,’’ after 
‘‘related to’’; and 
(2) in subsection (b), by inserting ‘‘addiction medicine,’’ 
after ‘‘psychiatry,’’. 
SEC. 203. MENTAL AND BEHAVIORAL HEALTH EDUCATION AND 
TRAINING GRANTS. 
Section 756(f) of the Public Health Service Act (42 U.S.C. 
294e–1(f)) is amended by striking ‘‘fiscal years 2023 through 2027’’ 
and inserting ‘‘fiscal years 2026 through 2030’’. 
SEC. 204. LOAN REPAYMENT PROGRAM FOR SUBSTANCE USE DIS-
ORDER TREATMENT WORKFORCE. 
Section 781(j) of the Public Health Service Act (42 U.S.C. 
295h(j)) is amended by striking ‘‘$25,000,000 for each of fiscal 
years 2019 through 2023’’ and inserting ‘‘$40,000,000 for each of 
fiscal years 2026 through 2030’’. 
SEC. 205. DEVELOPMENT AND DISSEMINATION OF MODEL TRAINING 
PROGRAMS FOR SUBSTANCE USE DISORDER PATIENT 
RECORDS. 
Section 7053 of the SUPPORT for Patients and Communities 
Act (42 U.S.C. 290dd–2 note) is amended by striking subsection 
(e). 
SEC. 206. TASK FORCE ON BEST PRACTICES FOR TRAUMA-INFORMED 
IDENTIFICATION, REFERRAL, AND SUPPORT. 
Section 7132 of the SUPPORT for Patients and Communities 
Act (Public Law 115–271; 132 Stat. 4046) is amended— 
(1) in subsection (b)(1)— 
(A) by redesignating subparagraph (CC) as subpara-
graph (DD); and 
(B) by inserting after subparagraph (BB) the following: 
‘‘(CC) The Administration for Community Living.’’;
H. R. 2483—13 
(2) in subsection (d)(1), in the matter preceding subpara-
graph (A), by inserting ‘‘, developmental disability service pro-
viders’’ before ‘‘, individuals who are’’; and 
(3) in subsection (i), by striking ‘‘2023’’ and inserting ‘‘2030’’. 
SEC. 207. GRANTS TO ENHANCE ACCESS TO SUBSTANCE USE DISORDER 
TREATMENT. 
Section 3203 of the SUPPORT for Patients and Communities 
Act (21 U.S.C. 823 note) is amended— 
(1) by striking subsection (b); and 
(2) by striking ‘‘(a) IN GENERAL.—The Secretary’’ and 
inserting the following: ‘‘The Secretary’’. 
SEC. 208. STATE GUIDANCE RELATED TO INDIVIDUALS WITH SERIOUS 
MENTAL ILLNESS AND CHILDREN WITH SERIOUS EMO-
TIONAL DISTURBANCE. 
(a) REVIEW OF USE OF CERTAIN FUNDING.—Not later than 1 
year after the date of enactment of this Act, the Secretary of 
Health and Human Services (referred to in this section as the 
‘‘Secretary’’), acting through the Assistant Secretary for Mental 
Health and Substance Use, shall conduct a review of State use 
of funds made available under the Community Mental Health Serv-
ices Block Grant program under subpart I of part B of title XIX 
of the Public Health Service Act (42 U.S.C. 300x et seq.) (referred 
to in this section as the ‘‘block grant program’’) for first episode 
psychosis activities. Such review shall consider the following: 
(1) How States use funds for evidence-based treatments 
and services according to the standard of care for individuals 
with early serious mental illness and children with a serious 
emotional disturbance. 
(2) The percentages of the State funding under the block 
grant program expended on early serious mental illness and 
first episode psychosis, and the number of individuals served 
under such funds. 
(b) REPORT AND GUIDANCE.— 
(1) REPORT.—Not later than 180 days after the completion 
of the review under subsection (a), the Secretary shall submit 
to the Committee on Health, Education, Labor, and Pensions 
and the Committee on Appropriations of the Senate and the 
Committee on Energy and Commerce and the Committee on 
Appropriations of the House of Representatives a report 
describing— 
(A) the findings of the review under subsection (a); 
and 
(B) any recommendations for changes to the block grant 
program that would facilitate improved outcomes for 
individuals with serious mental illness and children with 
serious emotional disturbance. 
(2) GUIDANCE.—Not later than 1 year after the date on 
which the report is submitted under paragraph (1), the Sec-
retary shall update the guidance provided to States under 
the block grant program on coordinated specialty care and 
other evidence-based mental health care services for individuals 
with serious mental illness and children with a serious emo-
tional disturbance, based on the findings and recommendations 
of such report.
H. R. 2483—14 
SEC. 209. REVIEWING THE SCHEDULING OF APPROVED PRODUCTS 
CONTAINING A COMBINATION OF BUPRENORPHINE AND 
NALOXONE. 
(a) SECRETARY OF HHS.—The Secretary of Health and Human 
Services shall, consistent with the requirements and procedures 
set forth in sections 201 and 202 of the Controlled Substances 
Act (21 U.S.C. 811, 812)— 
(1) review the relevant data pertaining to the scheduling 
of products containing a combination of buprenorphine and 
naloxone that have been approved under section 505 of the 
Federal Food, Drug, and Cosmetic Act (21 U.S.C. 355); and 
(2) if appropriate, request that the Attorney General ini-
tiate rulemaking proceedings to revise the schedules accordingly 
with respect to such products. 
(b) ATTORNEY GENERAL.—The Attorney General shall review 
any request made by the Secretary of Health and Human Services 
under subsection (a)(2) and determine whether to initiate pro-
ceedings to revise the schedules in accordance with the criteria 
set forth in sections 201 and 202 of the Controlled Substances 
Act (21 U.S.C. 811, 812). 
SEC. 210. REFERENCES TO OPIOID OVERDOSE REVERSAL AGENTS IN 
HHS GRANT PROGRAMS. 
(a) IN GENERAL.—The Secretary of Health and Human Services 
shall ensure that, as appropriate, whenever the Department of 
Health and Human Services issues a regulation or guidance for 
any grant program addressing opioid misuse and use disorders, 
any reference to an opioid overdose reversal drug (such as a ref-
erence to naloxone) is inclusive of any opioid overdose reversal 
drug that has been approved under section 505 of the Federal 
Food, Drug, and Cosmetic Act (21 U.S.C. 355) for emergency treat-
ment of a known or suspected opioid overdose. 
(b) EXISTING REFERENCES.— 
(1) UPDATE.—Not later than one year after the date of 
enactment of this Act, the Secretary of Health and Human 
Services shall update all references described in paragraph 
(2) to be inclusive of any opioid overdose reversal drug that 
has been approved or otherwise authorized for use by the 
Food and Drug Administration. 
(2) REFERENCES.—A reference described in this paragraph 
is any reference to an opioid overdose reversal drug (such 
as naloxone) in any regulation or guidance of the Department 
of Health and Human Services that— 
(A) was issued before the date of enactment of this 
Act; and 
(B) is included in— 
(i) the grant program for State and Tribal response 
to opioid use disorders under section 1003 of the 21st 
Century Cures Act (42 U.S.C. 290ee–3 note) (commonly 
referred to as ‘‘State Opioid Response Grants’’ and 
‘‘Tribal Opioid Response Grants’’); or 
(ii) the grant program for priority substance use 
disorder prevention needs of regional and national 
significance under section 516 of the Public Health 
Service Act (42 U.S.C. 290bb–22).
H. R. 2483—15 
SEC. 211. ROUNDTABLE ON USING HEALTH INFORMATION TECH-
NOLOGY TO IMPROVE MENTAL HEALTH AND SUBSTANCE 
USE CARE OUTCOMES. 
(a) ROUNDTABLE.—Not later than 180 days after the date of 
enactment of this Act, the National Coordinator for Health Informa-
tion Technology shall convene a public roundtable to examine— 
(1) how the expanded use of electronic health records 
among mental health and substance use service providers can 
improve outcomes for patients in mental health and substance 
use settings; and 
(2) how best to increase electronic health record adoption 
among such providers. 
(b) PARTICIPANTS.—The National Coordinator for Health 
Information Technology shall ensure that the participants in the 
roundtable under subsection (a) include private and public sector 
stakeholders, including patients, providers (including providers of 
inpatient services and providers of outpatient services), and rep-
resentatives of payors, health information exchanges, professional 
associations, health information technology vendors, health informa-
tion technology certification organizations, and State and Federal 
agencies. 
(c) REPORT.—Not later than 180 days after the conclusion of 
the public stakeholder roundtable under subsection (a), the National 
Coordinator for Health Information Technology shall submit to 
the Committee on Health, Education, Labor, and Pensions of the 
Senate and the Committee on Energy and Commerce of the House 
of Representatives a report outlining information gathered from 
the roundtable under subsection (a). Such report shall include an 
examination of— 
(1) recommendations from the roundtable participants; 
(2) unique considerations for using electronic health record 
systems in mental health and substance use treatment settings; 
(3) unique considerations for developers of health informa-
tion technology relating to certification of electronic health 
record systems for use in mental health and substance use 
treatment settings where the applicable health information 
technology is not subject to certification requirements; 
(4) current usage of electronic health record systems by 
mental health and substance use disorder service providers, 
and the scope and magnitude of such providers that do not 
use electronic health record systems; 
(5) examples of how electronic health record systems enable 
coordinated care and care management; 
(6) how electronic health record systems advance appro-
priate patient and provider access to secure, usable electronic 
information exchange; 
(7) how electronic health record systems can be connected 
to or support existing systems, which may include the 9–8– 
8 National Suicide Prevention Lifeline, mobile crisis response 
systems, and co-responder programs, to facilitate connectivity, 
response, and integrated care; 
(8) any existing programs to support greater adoption of 
electronic health record systems among mental health and sub-
stance use service providers; 
(9) any limitations to greater adoption of electronic health 
record systems among mental health and substance use service 
providers;
H. R. 2483—16 
(10) the costs of adoption of electronic health record systems 
by mental health and substance use disorder service providers; 
and 
(11) best practices implemented by States and other entities 
to support adoption of use of electronic health records among 
mental health and substance use disorder service providers. 
TITLE III—RECOVERY 
SEC. 301. BUILDING COMMUNITIES OF RECOVERY. 
Section 547(f) of the Public Health Service Act (42 U.S.C. 
290ee–2(f)) is amended by striking ‘‘$5,000,000 for each of fiscal 
years 2019 through 2023’’ and inserting ‘‘$17,000,000 for each of 
fiscal years 2026 through 2030’’. 
SEC. 302. PEER SUPPORT TECHNICAL ASSISTANCE CENTER. 
Section 547A of the Public Health Service Act (42 U.S.C. 290ee– 
2a) is amended— 
(1) in subsection (b)(4), by striking ‘‘building; and’’ and 
inserting the following: ‘‘building, such as— 
‘‘(A) professional development of peer support special-
ists; and 
‘‘(B) making recovery support services available in non-
clinical settings; and’’; 
(2) by redesignating subsections (d) and (e) as subsections 
(e) and (f), respectively; 
(3) by inserting after subsection (c) the following: 
‘‘(d) REGIONAL CENTERS.— 
‘‘(1) IN GENERAL.—The Secretary may establish one regional 
technical assistance center (referred to in this subsection as 
the ‘Regional Center’), with existing resources, to assist the 
Center in carrying out activities described in subsection (b) 
within the geographic region of such Regional Center in a 
manner that is tailored to the needs of such region. 
‘‘(2) EVALUATION.—Not later than 4 years after the date 
of enactment of the SUPPORT for Patients and Communities 
Reauthorization Act of 2025, the Secretary shall evaluate the 
activities of the Regional Center and submit to the Committee 
on Health, Education, Labor, and Pensions of the Senate and 
the Committee on Energy and Commerce of the House of Rep-
resentatives a report on the findings of such evaluation, 
including— 
‘‘(A) a description of the distinct roles and responsibil-
ities of the Regional Center and the Center; 
‘‘(B) available information relating to the outcomes of 
the Regional Center under this subsection, such as any 
impact on the operations and efficiency of the Center 
relating to requests for technical assistance and support 
within the region of such Regional Center; 
‘‘(C) a description of any gaps or areas of duplication 
relating to the activities of the Regional Center and the 
Center within such region; and 
‘‘(D) recommendations relating to the modification, 
expansion, or termination of the Regional Center under 
this subsection.
H. R. 2483—17 
‘‘(3) TERMINATION.—This subsection shall terminate on Sep-
tember 30, 2030.’’; and 
(4) in subsection (f), as so redesignated, by striking 
‘‘$1,000,000 for each of fiscal years 2019 through 2023’’ and 
inserting ‘‘$2,000,000 for each of fiscal years 2026 through 
2030’’. 
SEC. 303. COMPREHENSIVE OPIOID RECOVERY CENTERS. 
Section 552 of the Public Health Service Act (42 U.S.C. 290ee– 
7) is amended— 
(1) in subsection (d)(2)— 
(A) in the matter preceding subparagraph (A), by 
striking ‘‘and in such manner’’ and inserting ‘‘, in such 
manner, and containing such information and assurances, 
including relevant documentation,’’; and 
(B) in subparagraph (A), by striking ‘‘is capable of 
coordinating with other entities to carry out’’ and inserting 
‘‘has the demonstrated capability to carry out, through 
referral or contractual arrangements’’; 
(2) in subsection (h)— 
(A) by redesignating paragraphs (1) through (4) as 
subparagraphs (A) through (D), respectively, and adjusting 
the margins accordingly; 
(B) by striking ‘‘With respect to’’ and inserting the 
following: 
‘‘(1) IN GENERAL.—With respect to’’; and 
(C) by adding at the end the following: 
‘‘(2) ADDITIONAL REPORTING FOR CERTAIN ELIGIBLE ENTI-
TIES.—An entity carrying out activities described in subsection 
(g) through referral or contractual arrangements shall include 
in the submissions required under paragraph (1) information 
related to the status of such referrals or contractual arrange-
ments, including an assessment of whether such referrals or 
contractual arrangements are supporting the ability of such 
entity to carry out such activities.’’; and 
(3) in subsection (j), by striking ‘‘2019 through 2023’’ and 
inserting ‘‘2026 through 2030’’. 
SEC. 304. YOUTH PREVENTION AND RECOVERY. 
Section 7102(c) of the SUPPORT for Patients and Communities 
Act (42 U.S.C. 290bb–7a(c)) (as amended by section 110(a)) is 
amended— 
(1) in paragraph (2)— 
(A) in subparagraph (A)— 
(i) in clause (i)— 
(I) by inserting ‘‘, or a consortium of local 
educational agencies,’’ after ‘‘a local educational 
agency’’; and 
(II) by striking ‘‘high schools’’ and inserting 
‘‘secondary schools’’; and 
(ii) in clause (vi), by striking ‘‘tribe, or tribal’’ and 
inserting ‘‘Tribe, or Tribal’’; 
(B) by amending subparagraph (E) to read as follows: 
‘‘(E) INDIAN TRIBE; TRIBAL ORGANIZATION.—The terms 
‘Indian Tribe’ and ‘Tribal organization’ have the meanings 
given such terms in section 4 of the Indian Self-Determina-
tion and Education Assistance Act (25 U.S.C. 5304).’’;
H. R. 2483—18 
(C) by redesignating subparagraph (K) as subpara-
graph (L); and 
(D) by inserting after subparagraph (J) the following: 
‘‘(K) SECONDARY SCHOOL.—The term ‘secondary school’ 
has the meaning given such term in section 8101 of the 
Elementary and Secondary Education Act of 1965 (20 
U.S.C. 7801).’’; 
(2) in paragraph (3)(A), in the matter preceding clause 
(i)— 
(A) by striking ‘‘and abuse’’; and 
(B) by inserting ‘‘at increased risk for substance 
misuse’’ after ‘‘specific populations’’; 
(3) in paragraph (4)— 
(A) in the matter preceding subparagraph (A), by 
striking ‘‘Indian tribes’’ and inserting ‘‘Indian Tribes’’; 
(B) in subparagraph (A), by striking ‘‘and abuse’’; and 
(C) in subparagraph (B), by striking ‘‘peer mentoring’’ 
and inserting ‘‘peer-to-peer support’’; 
(4) in paragraph (5), by striking ‘‘tribal’’ and inserting 
‘‘Tribal’’; 
(5) in paragraph (6)(A)— 
(A) in clause (iv), by striking ‘‘; and’’ and inserting 
a semicolon; and 
(B) by adding at the end the following: 
‘‘(vi) a plan to sustain the activities carried out 
under the grant program, after the grant program 
has ended; and’’; 
(6) in paragraph (8), by striking ‘‘2022’’ and inserting 
‘‘2028’’; and 
(7) by amending paragraph (9) to read as follows: 
‘‘(9) AUTHORIZATION OF APPROPRIATIONS.—To carry out this 
subsection, there are authorized to be appropriated— 
‘‘(A) $10,000,000 for fiscal year 2026; 
‘‘(B) $12,000,000 for fiscal year 2027; 
‘‘(C) $13,000,000 for fiscal year 2028; 
‘‘(D) $14,000,000 for fiscal year 2029; and 
‘‘(E) $15,000,000 for fiscal year 2030.’’. 
SEC. 305. CAREER ACT. 
(a) IN GENERAL.—Section 7183 of the SUPPORT for Patients 
and Communities Act (42 U.S.C. 290ee–8) is amended— 
(1) in the section heading, by inserting ‘‘; TREATMENT, 
RECOVERY, AND WORKFORCE SUPPORT GRANTS’’ after ‘‘CAREER 
ACT’’; 
(2) in subsection (b), by inserting ‘‘each’’ before ‘‘for a 
period’’; 
(3) in subsection (c)— 
(A) in paragraph (1), by striking ‘‘the rates described 
in paragraph (2)’’ and inserting ‘‘the average rates for cal-
endar years 2018 through 2022 described in paragraph 
(2)’’; and 
(B) by amending paragraph (2) to read as follows: 
‘‘(2) RATES.—The rates described in this paragraph are 
the following: 
‘‘(A) The highest age-adjusted average rates of drug 
overdose deaths for calendar years 2018 through 2022 
based on data from the Centers for Disease Control and
H. R. 2483—19 
Prevention, including, if necessary, provisional data for 
calendar year 2022. 
‘‘(B) The highest average rates of unemployment for 
calendar years 2018 through 2022 based on data provided 
by the Bureau of Labor Statistics. 
‘‘(C) The lowest average labor force participation rates 
for calendar years 2018 through 2022 based on data pro-
vided by the Bureau of Labor Statistics.’’; 
(4) in subsection (g)— 
(A) in each of paragraphs (1) and (3), by redesignating 
subparagraphs (A) and (B) as clauses (i) and (ii), respec-
tively, and adjusting the margins accordingly; 
(B) by redesignating paragraphs (1) through (3) as 
subparagraphs (A) through (C), respectively, and adjusting 
the margins accordingly; 
(C) in the matter preceding subparagraph (A) (as so 
redesignated), by striking ‘‘An entity’’ and inserting the 
following: 
‘‘(1) IN GENERAL.—An entity’’; and 
(D) by adding at the end the following: 
‘‘(2) TRANSPORTATION
SERVICES.—An entity receiving a 
grant under this section may use not more than 5 percent 
of the funds for providing transportation for individuals to 
participate in an activity supported by a grant under this 
section, which transportation shall be to or from a place of 
work or a place where the individual is receiving vocational 
education or job training services or receiving services directly 
linked to treatment of or recovery from a substance use dis-
order. 
‘‘(3) LIMITATION.—The Secretary may not require an entity 
to, or give priority to an entity that plans to, use the funds 
of a grant under this section for activities that are not specified 
in this subsection.’’; 
(5) in subsection (i)(2), by inserting ‘‘, which shall include 
employment and earnings outcomes described in subclauses 
(I) and (III) of section 116(b)(2)(A)(i) of the Workforce Innova-
tion and Opportunity Act (29 U.S.C. 3141(b)(2)(A)(i)) with 
respect to the participation of such individuals with a substance 
use disorder in programs and activities funded by the grant 
under this section’’ after ‘‘subsection (g)’’; 
(6) in subsection (j)— 
(A) in paragraph (1), by inserting ‘‘for grants awarded 
prior to the date of enactment of the SUPPORT for Patients 
and Communities Reauthorization Act of 2025’’ after ‘‘grant 
period under this section’’; and 
(B) in paragraph (2)— 
(i) in the matter preceding subparagraph (A), by 
striking ‘‘2 years after submitting the preliminary 
report required under paragraph (1)’’ and inserting 
‘‘September 30, 2030’’; and 
(ii) in subparagraph (A), by striking ‘‘(g)(3)’’ and 
inserting ‘‘(g)(1)(C)’’; and 
(7) in subsection (k), by striking ‘‘$5,000,000 for each of 
fiscal years 2019 through 2023’’ and inserting ‘‘$12,000,000 
for each of fiscal years 2026 through 2030’’. 
(b) REAUTHORIZATION
OF
THE
CAREER ACT; RECOVERY 
HOUSING PILOT PROGRAM.—
H. R. 2483—20 
(1) IN
GENERAL.—Section 8071 of the SUPPORT for 
Patients and Communities Act (42 U.S.C. 5301 note; Public 
Law 115–271) is amended— 
(A) by striking the section heading and inserting 
‘‘CAREER ACT; RECOVERY HOUSING PILOT PROGRAM’’; 
(B) in subsection (a), by striking ‘‘through 2023’’ and 
inserting ‘‘through 2030’’; 
(C) in subsection (b)— 
(i) in paragraph (1), by striking ‘‘not later than 
60 days after the date of enactment of this Act’’ and 
inserting ‘‘not later than 60 days after the date of 
enactment of the SUPPORT for Patients and Commu-
nities Reauthorization Act of 2025’’; and 
(ii) in paragraph (2)(B)(i)— 
(I) in subclause (I)— 
(aa) by striking ‘‘for calendar years 2013 
through 2017’’; and 
(bb) by inserting ‘‘for calendar years 2018 
through 2022’’ after ‘‘rates of unemployment’’; 
(II) in subclause (II)— 
(aa) by striking ‘‘for calendar years 2013 
through 2017’’; and 
(bb) by inserting ‘‘for calendar years 2018 
through 2022’’ after ‘‘participation rates’’; and 
(III) by striking subclause (III) and inserting 
the following: 
‘‘(III) The highest age-adjusted average rates 
of drug overdose deaths for calendar years 2018 
through 2022 based on data from the Centers for 
Disease Control and Prevention, including, if nec-
essary, provisional data for calendar year 2022.’’; 
and 
(D) in subsection (f), by striking ‘‘For the 2-year period 
following the date of enactment of this Act, the’’ and 
inserting ‘‘The’’. 
(2) CONFORMING AMENDMENT.—Subtitle F of title VIII of 
the SUPPORT for Patients and Communities Act (Public Law 
115–271; 132 Stat. 4095) is amended by striking the subtitle 
heading and inserting the following: ‘‘Subtitle F—CAREER 
Act; Recovery Housing Pilot Program’’ . 
(c) CLERICAL AMENDMENTS.—The table of contents in section 
1(b) of the SUPPORT for Patients and Communities Act (Public 
Law 115–271; 132 Stat. 3894) is amended— 
(1) by striking the item relating to section 7183 and 
inserting the following: 
‘‘Sec. 7183. CAREER Act; treatment, recovery, and workforce support grants.’’; 
(2) by striking the item relating to subtitle F of title VIII 
and inserting the following: 
‘‘Subtitle F—CAREER Act; Recovery Housing Pilot Program’’; and 
(3) by striking the item relating to section 8071 and 
inserting the following: 
‘‘Sec. 8071. CAREER Act; Recovery Housing Pilot Program.’’.
H. R. 2483—21 
SEC. 306. ADDRESSING ECONOMIC AND WORKFORCE IMPACTS OF THE 
OPIOID CRISIS. 
Section 8041(g)(1) of the SUPPORT for Patients and Commu-
nities Act (29 U.S.C. 3225a(g)(1)) is amended by striking ‘‘2023’’ 
and inserting ‘‘2030’’. 
SEC. 
307. 
REVIEW 
OF 
INFORMATION 
RELATED 
TO 
FUNDING 
OPPORTUNITIES UNDER PROGRAMS ADMINISTERED BY 
SAMHSA. 
(a) IN GENERAL.—Not later than one year after the date of 
enactment of this Act, the Secretary of Health and Human Services 
(referred to in this section as the ‘‘Secretary’’) shall convene a 
public meeting for purposes of improving awareness of, and access 
to, information related to current and future funding opportunities 
under programs administered by the Substance Abuse and Mental 
Health Services Administration (in this section referred to as 
‘‘SAMHSA funding opportunities’’). 
(b) TOPICS.—The public meeting under subsection (a) shall 
include— 
(1) opportunities to improve the utility and functionality 
of internet websites maintained by the Secretary that provide 
information related to SAMHSA funding opportunities, such 
as Grants.gov; 
(2) other models for displaying and disseminating informa-
tion related to SAMHSA funding opportunities, such as inter-
active dashboards; and 
(3) strategies to improve the ability of entities to apply 
for SAMHSA funding opportunities, including entities that have 
not traditionally applied for SAMHSA funding opportunities. 
(c) WEBSITE IMPROVEMENTS.—The Secretary shall implement 
improvements to Grants.gov related to SAMHSA funding opportuni-
ties based on stakeholder feedback received at the public meeting 
under subsection (a), as appropriate, to the maximum extent fea-
sible. 
(d) REPORT.—Not later than one year after the date on which 
the public meeting under subsection (a) is convened, the Secretary 
shall submit to the Committee on Health, Education, Labor, and 
Pensions of the Senate and the Committee on Energy and Com-
merce of the House of Representatives a report summarizing the 
findings of such meeting, including how the Secretary has taken 
into account the feedback received through such meeting and imple-
mented— 
(1) improvements to internet websites maintained by the 
Secretary that provide information related to SAMHSA funding 
opportunities; and 
(2) strategies to improve awareness of SAMHSA funding 
opportunities. 
TITLE IV—MISCELLANEOUS MATTERS 
SEC. 401. DELIVERY OF A CONTROLLED SUBSTANCE BY A PHARMACY 
TO A PRESCRIBING PRACTITIONER. 
Section 309A(a) of the Controlled Substances Act (21 U.S.C. 
829a(a)) is amended by striking paragraph (2) and inserting the 
following:
H. R. 2483—22 
‘‘(2) the controlled substance is a drug in schedule III, 
IV, or V to be administered— 
‘‘(A) by injection or implantation for the purpose of 
maintenance or detoxification treatment; or 
‘‘(B) subject to a risk evaluation and mitigation strategy 
pursuant to section 505–1 of the Federal Food, Drug, and 
Cosmetic Act (21 U.S.C. 355–1) that includes elements 
to assure safe use of the drug described in subsection 
(f)(3)(E) of such section, including a requirement for post- 
administration monitoring by a health care provider;’’. 
SEC. 402. REQUIRED TRAINING FOR PRESCRIBERS OF CONTROLLED 
SUBSTANCES. 
(a) IN GENERAL.—Section 303 of the Controlled Substances 
Act (21 U.S.C. 823) is amended— 
(1) by redesignating the second subsection designated as 
subsection (l) as subsection (m); and 
(2) in subsection (m)(1), as so redesignated— 
(A) in subparagraph (A)— 
(i) in clause (iv)— 
(I) in subclause (I)— 
(aa) by inserting ‘‘the American Academy 
of Family Physicians, the American Podiatric 
Medical Association, the Academy of General 
Dentistry, the American Optometric Associa-
tion,’’ before ‘‘or any other organization’’; 
(bb) by striking ‘‘or the Commission’’ and 
inserting ‘‘, the Commission’’; and 
(cc) by inserting ‘‘, or the Council on 
Podiatric Medical Education’’ before the semi-
colon at the end; and 
(II) in subclause (III), by inserting ‘‘or the 
American Academy of Family Physicians’’ after 
‘‘Association’’; and 
(ii) in clause (v), in the matter preceding subclause 
(I)— 
(I) by striking ‘‘osteopathic medicine, dental 
surgery’’ and inserting ‘‘osteopathic medicine, 
podiatric medicine, dental surgery’’; and 
(II) by striking ‘‘or dental medicine cur-
riculum’’ and inserting ‘‘or dental or podiatric 
medicine curriculum’’; and 
(B) in subparagraph (B)— 
(i) in clause (i)— 
(I) by inserting ‘‘the American Pharmacists 
Association, the Accreditation Council on Phar-
macy Education, the American Psychiatric Nurses 
Association, the American Academy of Nursing, 
the American Academy of Family Physicians,’’ 
before ‘‘or any other organization’’; and 
(II) by inserting ‘‘, the American Academy of 
Family Physicians,’’ before ‘‘or the Accreditation 
Council’’; and 
(ii) in clause (ii)— 
(I) by striking ‘‘or accredited school’’ and 
inserting ‘‘, an accredited school’’; and